| CAS No.: | 3458-28-4 |
|---|---|
| Formula: | C6h12o6 |
| EINECS: | 222-392-4 |
| Environmental Protection: | Yes |
| Color: | White Crystals or Crystalline Powder |
| Classification: | Pharmaceutical Ingredients |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
Product Name: D-mannose
Specification: 99.0%
Appearance: A white crystalline powder
| PRODUCT SPECIFICATIONS | ||
| Product Name: | D-mannose | |
| Internal Code: | 000-00451 | |
| Botanic Name: | Saccharum officinarum | |
| Scientific name(Family/Genus/Species) | Poaceae/Saccharum/S.officinarum | |
| Part of plant | Ramus | |
| Solvent extraction | 20% Water & 80% ethanol | |
| Country of Origin: | China | |
| Excipent | None | |
| ANALYSIS ITEMS | SPECIFICATION | TEST METHOD |
| Appearance | Fine powder | Organoleptic |
| Color | White | Visual |
| Odour & Taste | Characteristic | Organoleptic |
| Identification | Identical to R.S. sample | HPTLC |
| D-mannose | NLT 99.0% | HPLC |
| Extract ratio | 20:1 | |
| Solubility | Not soluble in water | |
| Hydrocarbons PAHs | ≤ 50 ppb -Reg.UE 1933/2015 | GC-MS |
| Benzo(a)pyren | ≤ 10 ppb -Reg.UE 1933/2015 | GC-MS |
| Radioactivity | ≤ 600 Bq/Kg -Reg. CE 1409/2009 | |
| Apparent density | 0.4-0.7g/ml | |
| Sieve Analysis | 100% through 80 mesh | USP39 <786> |
| Loss on drying | ≤ 0.1% | Eur.Ph.9.0 [2.5.12] |
| Total Ash | ≤ 0.05% | Eur.Ph.9.0 [2.4.16] |
| Lead (Pb) | ≤ 3.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Arsenic (As) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Cadmium(Cd) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Mercury(Hg) | ≤ 0.1 mg/kg -Reg.EC629/2008 | Eur.Ph.9.0<2.2.58>ICP-MS |
| Heavy metal | ≤ 10.0 mg/kg | Eur.Ph.9.0<2.4.8> |
| Solvents Residue | Conform Eur.ph. 9.0 <5,4 > and EC European Directive 2009/32 | Eur.Ph.9.0<2.4.24> |
| Pesticides Residues | Conform Regulations(EC) No.396/2005 including annexes and successive updates Reg.2008/839/CE | Gas Chromatography |
| Aerobic bacteria(TAMC) | ≤1000 cfu/g | USP39 <61> |
| Yeast/Moulds(TAMC) | ≤100 cfu/g | USP39 <61> |
| Bile-tol.gram- b./Enterobact.: | ≤100 cfu/g | |
| Escherichia coli: | Absent in 1g | USP39 <62> |
| Salmonella spp: | Absent in 25g | USP39 <62> |
| Staphylococcus aureus: | Absent in 1g | |
| Listeria Monocytogenens | Absent in 25g | |
| Aflatoxins B1 | ≤ 5 ppb -Reg.EC 1881/2006 | USP39 <62> |
| Aflatoxins ∑ B1, B2, G1, G2 | ≤ 10 ppb -Reg.EC 1881/2006 | USP39 <62> |
| Irradiation | No Irradiation | |
| GMO | Product No-GMO (Reg.1829/2003-1830/2003 EC) | |
| Allergens | Non allergen, in compliance with Reg.1169/2011 Annex II | |
| BSE/TSE | Free, the product doesn't contain animal materials | |
| Melamine | Free, No melamine(Reg.EU 594/2012) | |
| Ethylen-oxide | No Ethylen-oixde | |
| Vegan | Yes | |
| Packing | Pack in paper-drums and two plastic-bags inside N.W. 25 kgs I.D.35xH51cm. | |
| Storage | Store in a well-closed container away from moisture, light, oxygen. | |
| Shelf Life | 24 months under the conditions above and in its original packaging | |
1.D-Mannose can be used for additives of food and beverage. Rehabilitation of diabetes, obesity, constipation and high cholesterol and so on have a good supporting role.
2. D-Mannose has anti-inflammatory effect,can inhibit the inflammatory response during wound healing. In addition, mannose derivatives has anti-effect of peritonitis and adjuvant arthritis.
3.Inhibition of tumor growth and prevent parasites,bactena, viruses and bactenal intections.
4. D-Mannose also is one of medicines component to improve sleep.
5. D-Mannose maintain urinary tract health purposes in an effective way and will not interfere with blood sugar regulation
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}